Biogenerics to help save nearly $100 bn over 10 yrs

Reghu Balakrishnan
Posted: Thursday, Aug 07, 2008 at 0008 hrs IST
Updated: Thursday, Aug 07, 2008 at 0008 hrs IST

Font Size

Feedback

Discuss

Mumbai, Aug 6: share as healthcare bills are being challenged by mounting costs and need to address affordability through biogenerics. We have developed a pipeline of generic biotech drugs like Insulin, GCSF, EPO, Streptokinase, Glargine etc. and we are already enjoying increased market share in several international markets especially for Insulin. It will be interesting to see how Biotech companies who enjoyed protection from generic competition will respond."...

Discuss this story on expressindia forums

Post Comments

Comments: (Limit 3,000 characters)

Name		Message
Email ID
Subject

TERMS OF USE:
The views, opinions and comments posted are your, and are not endorsed by this website. You shall be solely responsible for the comment posted here. The website reserves the right to delete, reject, or otherwise remove any views, opinions and comments posted or part thereof. You shall ensure that the comment is not inflammatory, abusive, derogatory, defamatory &/or obscene, or contain pornographic matter and/or does not constitute hate mail, or violate privacy of any person (s) or breach confidentiality or otherwise is illegal, immoral or contrary to public policy. Nor should it contain anything infringing copyright &/or intellectual property rights of any person(s).

I agree to the terms of use.

Latest News

Print Edition

Events

Biogenerics to help save nearly $100 bn over 10 yrs

Post Comments